Thakkar Roopal has filed 23 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 8037 shares of AbbVie Inc. ($ABBV) on February 27, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | F | Common Stock, $0.01 par value | 8037 | $232.08 | 55,374.0000 | 1,773,000,000 | 12.67% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 6015 | $0.00 | 48,291.0000 | 1,773,000,000 | 14.23% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Option (Right to buy) | 21937 | $0.00 | 21,937.0000 | 1,773,000,000 | 9999.99% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 6638 | $0.00 | 60,413.0000 | 1,773,000,000 | 12.34% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 3346 | $0.00 | 53,775.0000 | 1,773,000,000 | 6.64% | 0.00% |
| Feb. 18, 2026 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 2138 | $0.00 | 50,429.0000 | 1,773,000,000 | 4.43% | 0.00% |
| Feb. 28, 2025 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | F | Common Stock, $0.01 par value | 4678 | $205.02 | 42,276.0000 | 1,773,000,000 | 9.96% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 3595 | $0.00 | 39,994.0000 | 1,773,000,000 | 9.88% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Option (Right to buy) | 25000 | $0.00 | 25,000.0000 | 1,773,000,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 3348 | $0.00 | 46,954.0000 | 1,773,000,000 | 7.68% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 2138 | $0.00 | 43,606.0000 | 1,773,000,000 | 5.16% | 0.00% |
| Feb. 13, 2025 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 1474 | $0.00 | 41,468.0000 | 1,773,000,000 | 3.69% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 2140 | $0.00 | 41,313.0000 | 1,773,000,000 | 5.46% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 5900 | $0.00 | 36,125.0000 | 1,773,000,000 | 19.52% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 1572 | $0.00 | 37,697.0000 | 1,773,000,000 | 4.35% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Common Stock, $0.01 par value | 1476 | $0.00 | 39,173.0000 | 1,773,000,000 | 3.92% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | EVP, R&D and CSO | A | Option (Right to buy) | 13868 | $0.00 | 13,868.0000 | 1,773,000,000 | 9999.99% | 0.00% |
| Feb. 28, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | F | Common Stock, $0.01 par value | 4914 | $178.99 | 23,259.0000 | 1,773,000,000 | 17.44% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | A | Common Stock, $0.01 par value | 8022 | $0.00 | 18,399.0000 | 1,773,000,000 | 77.31% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | A | Common Stock, $0.01 par value | 2138 | $0.00 | 20,537.0000 | 1,773,000,000 | 11.62% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | A | Common Stock, $0.01 par value | 1844 | $0.00 | 22,381.0000 | 1,773,000,000 | 8.98% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | A | Common Stock, $0.01 par value | 5792 | $0.00 | 28,173.0000 | 1,773,000,000 | 25.88% | 0.00% |
| Feb. 15, 2024 | AbbVie Inc. | $ABBV | Thakkar Roopal | SVP, CMO, GLOBAL THERAPEUTICS | A | Option (Right to buy) | 13868 | $0.00 | 13,868.0000 | 1,773,000,000 | 9999.99% | 0.00% |